switching from glp 1 to tirzepatide vs. Semaglutide: What You Should Know Can I Switch to Mounjaro®

High ATP amounts induce the closure of potassium channels, depolarizing the cell membrane, leading to calcium influx and insulin vesicle release

One is a selective MC1R agonist that has passed phase III human trials, with its safety backed by years of clinical data and full regulatory approval in the EU and USA

However, a July 2025 study published in eClinicalMedicine notes that people who stop taking Ozempic and other GLP-1s tend to regain the weight they had lost

These clinical trial figures may differ from real-world experience

Campo, G

3.6 Potential Microbiome Changes GLP-1 receptor agonists alter: Gastric motility Transit time Food intake patterns Emerging research suggests that weight loss and altered dietary intake may influence gut microbiota composition. At present, there is insufficient evidence to conclude that GLP-1 drugs independently cause clinically significant microbiome-mediated nutrient depletion